Paeds SAQs · endocrinology-diabetes-and-growth
Phaeochromocytoma and endocrine hypertension — formative SAQs
Two formative SAQs on phaeochromocytoma and endocrine hypertension in children: the hypertensive adolescent with headache, sweating and palpitations, testing the metanephrines-first rule, the alpha-before-beta preoperative sequence and the hereditary genetics; and the hypertensive child with hypokalaemia and suppressed renin and aldosterone, testing the renin–aldosterone fork and the monogenic mineralocorticoid causes.
On this page & tools
Target exams
SAQ 1 — The hypertensive adolescent with spells (20 marks, ~15 minutes)
A 14-year-old boy presents with a six-month history of episodes of severe headache, generalised sweating, palpitations and anxiety lasting minutes, with pallor noted by his mother. Between episodes he feels well. His blood pressure is 160/100, sustained on repeat measurement, and his heart rate is 96. A catecholamine-secreting tumour is suspected. [4]
Questions
- State the best first-line biochemical test and explain why it is preferred over a random catecholamine level. (4 marks) [3]
- Outline the imaging strategy once biochemistry is positive, including functional imaging. (5 marks) [1]
- Describe the mandatory preoperative pharmacological preparation, stating the sequence and the consequence of getting it wrong. (6 marks) [1]
- Explain why every child with this diagnosis needs a hereditary gene panel, and name the gene that flags metastatic extra-adrenal disease. (5 marks) [2]
Model answer (must-hit)
- Measure plasma free metanephrines or a twenty-four-hour urine fractionated metanephrines collection. These are preferred because the tumour cell continually converts catecholamines to metanephrines (noradrenaline to normetanephrine, adrenaline to metanephrine), which leak into the bloodstream continuously, whereas catecholamine release is episodic from stored vesicles. A random catecholamine level drawn between spells reads normal and misses the tumour; metanephrines do not. [3]
- Start with CT or MRI of the abdomen and pelvis (MRI preferred in children to avoid radiation) because most tumours lie in the adrenal gland or the organ of Zückerkandl. Then characterise and stage with functional imaging — iodine-123 MIBG scintigraphy or, increasingly, gallium-68 DOTATATE PET, which is more sensitive for metastatic and hereditary disease. [1]
- Alpha-blockade first, then beta-blockade. Start phenoxybenzamine at around 0.5 mg per kilogram per day in divided doses and titrate over ten to fourteen days until the child is normotensive or mildly hypotensive with an orthostatic drop and nasal stuffiness — the block-and-fill end-point. Add a beta-blocker only once the child is fully alpha-blocked, to control reflex tachycardia. Giving a beta-blocker first removes beta-two vasodilator tone and leaves unopposed alpha-one vasoconstriction, precipitating a fatal hypertensive crisis. [1]
- Around forty percent of paediatric phaeochromocytomas and paragangliomas carry a pathogenic germline mutation, far above adults, so every child earns a gene panel covering SDHx, VHL, RET, NF1, TMEM127, MAX and FH. Identifying the mutation predicts tumour behaviour, sets the surveillance schedule and enables cascade testing of relatives. An SDHB mutation flags extra-adrenal paraganglioma with metastatic potential. [2]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References9Show ledgerHide ledger
- [1]Lenders JW; Duh QY; Eisenhofer G; et al Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2014.PMID 24893135
- [2]Casey RT; Hendriks E; Deal C; et al International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents. Nat Rev Endocrinol, 2024.PMID 39147856
- [3]Lenders JW; Pacak K; Walther MM; et al Biochemical diagnosis of pheochromocytoma: which test is best? JAMA, 2002.PMID 11903030
- [4]Barontini M; Levin G; Sanso G Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci, 2006.PMID 17102069
- [5]Havekes B; Romijn JA; Eisenhofer G; et al Update on pediatric pheochromocytoma. Pediatr Nephrol, 2009.PMID 18566838
- [7]Muth A; Crona J; Gimm O; et al Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma. J Intern Med, 2019.PMID 30536464
- [8]Castinetti F; Waguespack SG; Machens A; et al Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol, 2019.PMID 30660595
- [11]New MI; Geller DS; Fallo F; et al Monogenic low renin hypertension. Trends Endocrinol Metab, 2005.PMID 15808805
- [12]Garovic VD; Hilliard AA; Turner ST Monogenic forms of low-renin hypertension. Nat Clin Pract Nephrol, 2006.PMID 17066054